Korro Bio (KRRO) Non-Current Assets (2018 - 2026)

Korro Bio (KRRO) has reported Non-Current Assets for 9 consecutive years, with $42.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets fell 44.96% year-over-year to $42.8 million; the trailing twelve-month figure through Jun 2026 stood at $200.7 million (down 41.69% YoY), and the FY2025 full-year result was $31.1 million, down 67.13% from the prior year.
• Non-Current Assets declined to $42.8 million in Q2 2026 per KRRO's latest filing, from $63.5 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $94.7 million in Q4 2024 and bottomed at $3.8 million in Q3 2023.
• Historically, Non-Current Assets has averaged $51.8 million across 5 years, with a median of $47.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Non-Current Assets tumbled 89.01% in 2023, then surged 2258.02% in 2024.
• Over 5 years, Non-Current Assets stood at $16.7 million in 2022, then soared by 193.75% to $48.9 million in 2023, then jumped by 93.54% to $94.7 million in 2024, then slumped by 67.13% to $31.1 million in 2025, then jumped by 37.52% to $42.8 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $42.8 million, $63.5 million, and $31.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.